0001127602-19-021143.txt : 20190607 0001127602-19-021143.hdr.sgml : 20190607 20190607174153 ACCESSION NUMBER: 0001127602-19-021143 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190606 FILED AS OF DATE: 20190607 DATE AS OF CHANGE: 20190607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KALKSTEIN MICHAEL CENTRAL INDEX KEY: 0001183216 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-08597 FILM NUMBER: 19887018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COOPER COMPANIES INC CENTRAL INDEX KEY: 0000711404 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 942657368 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 BUSINESS ADDRESS: STREET 1: 6140 STONERIDGE MALL RD STREET 2: STE 590 CITY: PLEASANTON STATE: CA ZIP: 94588 BUSINESS PHONE: 9254603600 MAIL ADDRESS: STREET 1: 6140 STONERIDGE MALL ROAD STREET 2: SUITE 590 CITY: PLEASANTON STATE: CA ZIP: 94588 FORMER COMPANY: FORMER CONFORMED NAME: COOPERVISION INC DATE OF NAME CHANGE: 19870701 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2019-06-06 0000711404 COOPER COMPANIES INC COO 0001183216 KALKSTEIN MICHAEL 6140 STONERIDGE MALL DRIVE SUITE 590 PLEASANTON CA 94588 1 Common Stock 2019-06-06 4 M 0 3500 49.57 A 9838 I The Kalkstein and English Family Trust u/a/d May 18, 2005 Common Stock 2019-06-06 4 S 0 3500 316.2813 D 6338 I The Kalkstein and English Family Trust u/a/d May 18, 2005 Common Stock 0 D Stock Options (Right to Buy) 49.57 2019-06-06 4 M 0 3500 0 D 2020-10-31 Common Stock 3500 3000 I The Kalkstein and English Family Trust u/a/d May 18, 2005, as amended The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.2511 to $316.4611. The reporting person undertakes to provide to The Cooper Companies, Inc., any security holder of The Cooper Companies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4. All shares granted under this option are currently exercisable. /s/ Michael H. Kalkstein 2019-06-07